Tri Locum Partners’s Celldex Therapeutics CLDX Stock Holding History

Tri Locum Partners’s Portfolio CLDX Stock Details CLDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$7.85M	Sell
2022 Q3	$6.71M	Buy
2022 Q2	$3.56M	Sell
2022 Q1	$13.1M	Buy
2021 Q3	–	Sell
2021 Q2	$5.86M	Sell
2021 Q1	$4.05M	Buy